Skip to main content
Premium Trial:

Request an Annual Quote

Sherrie Perkins, Andrew Theurer, Edgar Braendle

Sherrie Perkins has accepted the postion of CEO of ARUP Laboratories, while Andrew Theurer has accepted the position of president at the lab. They replace Edgar Braendle who served in both positions during the past year. Braendle is leaving ARUP to pursue other opportunities and rejoin his family in New Jersey, ARUP said. Perkins was previously senior vice president of R&D at ARUP, as well as professor, vice chair, and division chief of clinical pathology. She is a tenured professor at the University of Utah School of Medicine. Theurer was senior VP and CFO at ARUP. 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.